Therefore, the activity of ACSL 4 molecule and its mediated ferroptosis show its potential as a future therapeutic target for GIST, whether by inhibiting the ubiquitination of TRIM21 or promoting the deubiquitination of USP 15. This evidence concerns the gene TRIM21 and gastrointestinal stromal tumor.